# Ranger Energy Services, Inc.: financial statements, quarterly

RNGR · NYSE · CIK 1699039 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rngr.md) · [Financials](/companies/rngr/financials.md) · [Filings](/companies/rngr/filings.md) · [Insiders](/companies/rngr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rngr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [163](/filings/0001699039-24-000095.md) | [164](/filings/0001699039-24-000121.md) | [152 d](/filings/0001699039-25-000015.md) | [137](/filings/0001699039-25-000050.md) | [138](/filings/0001699039-25-000084.md) | [153](/filings/0001628280-25-051148.md) | [143 d](/filings/0001628280-26-015248.md) | [135](/filings/0001699039-26-000001.md) | [141](/filings/0001699039-25-000084.md) | [129](/filings/0001628280-25-051148.md) | [142 d](/filings/0001628280-26-015248.md) | [159](/filings/0001699039-26-000001.md) |
| Operating income | $m | [11.4](/filings/0001699039-24-000095.md) | [11.7](/filings/0001699039-24-000121.md) | [4.6 d](/filings/0001699039-25-000015.md) | [(0.5)](/filings/0001699039-25-000050.md) | [7.3](/filings/0001699039-25-000084.md) | [12.9](/filings/0001628280-25-051148.md) | [8.9 d](/filings/0001628280-26-015248.md) | [1.0](/filings/0001699039-26-000001.md) | [8.6](/filings/0001699039-25-000084.md) | [2.6](/filings/0001628280-25-051148.md) | [3.2 d](/filings/0001628280-26-015248.md) | [5.1](/filings/0001699039-26-000001.md) |
| Interest expense | $m | [0.9](/filings/0001699039-23-000099.md) | [0.7](/filings/0001699039-23-000128.md) | [0.7 d](/filings/0001699039-24-000025.md) | [0.8](/filings/0001699039-24-000067.md) | [0.6](/filings/0001699039-25-000084.md) | [0.7](/filings/0001628280-25-051148.md) | [0.5 d](/filings/0001628280-26-015248.md) | [0.5](/filings/0001699039-26-000001.md) | [0.1](/filings/0001699039-25-000084.md) | [0.4](/filings/0001628280-25-051148.md) | [0.2 d](/filings/0001628280-26-015248.md) | [0.8](/filings/0001699039-26-000001.md) |
| Income tax | $m | [2.0](/filings/0001699039-24-000095.md) | [1.6](/filings/0001699039-24-000121.md) | [1.8 d](/filings/0001699039-25-000015.md) | [(0.5)](/filings/0001699039-25-000050.md) | [2.0](/filings/0001699039-25-000084.md) | [3.5](/filings/0001628280-25-051148.md) | [2.6 d](/filings/0001628280-26-015248.md) | [(0.1)](/filings/0001699039-26-000001.md) | [2.8](/filings/0001699039-25-000084.md) | [1.3](/filings/0001628280-25-051148.md) | [1.5 d](/filings/0001628280-26-015248.md) | [1.0](/filings/0001699039-26-000001.md) |
| Net income | $m | [6.1](/filings/0001699039-24-000095.md) | [9.4](/filings/0001699039-24-000121.md) | [2.1 d](/filings/0001699039-25-000015.md) | [(0.8)](/filings/0001699039-25-000050.md) | [4.7](/filings/0001699039-25-000084.md) | [8.7](/filings/0001628280-25-051148.md) | [5.8 d](/filings/0001628280-26-015248.md) | [0.6](/filings/0001699039-26-000001.md) | [7.3](/filings/0001699039-25-000084.md) | [1.2](/filings/0001628280-25-051148.md) | [3.2 d](/filings/0001628280-26-015248.md) | [3.0](/filings/0001699039-26-000001.md) |
| Diluted EPS | $ per share | [0.24](/filings/0001699039-24-000095.md) | [0.38](/filings/0001699039-24-000121.md) | not reported | [(0.03)](/filings/0001699039-25-000050.md) | [0.21](/filings/0001699039-25-000084.md) | [0.39](/filings/0001628280-25-051148.md) | not reported | [0.03](/filings/0001699039-26-000001.md) | [0.32](/filings/0001699039-25-000084.md) | [0.05](/filings/0001628280-25-051148.md) | not reported | [0.12](/filings/0001699039-26-000001.md) |
| Basic EPS | $ per share | [0.25](/filings/0001699039-24-000095.md) | [0.38](/filings/0001699039-24-000121.md) | not reported | [(0.04)](/filings/0001699039-25-000050.md) | [0.21](/filings/0001699039-25-000084.md) | [0.39](/filings/0001628280-25-051148.md) | not reported | [0.03](/filings/0001699039-26-000001.md) | [0.33](/filings/0001699039-25-000084.md) | [0.06](/filings/0001628280-25-051148.md) | not reported | [0.13](/filings/0001699039-26-000001.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.4](/filings/0001699039-23-000099.md) | [8.2](/filings/0001699039-23-000128.md) | [15.7](/filings/0001699039-25-000015.md) | [11.1](/filings/0001699039-24-000067.md) | [8.7](/filings/0001699039-24-000095.md) | [14.8](/filings/0001699039-24-000121.md) | [40.9](/filings/0001628280-26-015248.md) | [40.3](/filings/0001699039-25-000050.md) | [48.9](/filings/0001699039-25-000084.md) | [45.2](/filings/0001628280-25-051148.md) | [10.3](/filings/0001699039-26-000001.md) | [6.9](/filings/0001699039-26-000001.md) |
| Current assets | $m | [128](/filings/0001699039-23-000099.md) | [151](/filings/0001699039-23-000128.md) | [135](/filings/0001699039-25-000015.md) | [117](/filings/0001699039-24-000067.md) | [114](/filings/0001699039-24-000095.md) | [133](/filings/0001699039-24-000121.md) | [144](/filings/0001628280-26-015248.md) | [144](/filings/0001699039-25-000050.md) | [152](/filings/0001699039-25-000084.md) | [147](/filings/0001628280-25-051148.md) | [121](/filings/0001699039-26-000001.md) | [159](/filings/0001699039-26-000001.md) |
| Total assets | $m | [365](/filings/0001699039-23-000099.md) | [394](/filings/0001699039-23-000128.md) | [378](/filings/0001699039-25-000015.md) | [356](/filings/0001699039-24-000067.md) | [360](/filings/0001699039-24-000095.md) | [374](/filings/0001699039-24-000121.md) | [382](/filings/0001628280-26-015248.md) | [377](/filings/0001699039-25-000050.md) | [382](/filings/0001699039-25-000084.md) | [373](/filings/0001628280-25-051148.md) | [419](/filings/0001699039-26-000001.md) | [459](/filings/0001699039-26-000001.md) |
| Current liabilities | $m | [60.3](/filings/0001699039-23-000099.md) | [79.6](/filings/0001699039-23-000128.md) | [69.0](/filings/0001699039-25-000015.md) | [58.0](/filings/0001699039-24-000067.md) | [61.5](/filings/0001699039-24-000095.md) | [66.5](/filings/0001699039-24-000121.md) | [65.2](/filings/0001628280-26-015248.md) | [62.3](/filings/0001699039-25-000050.md) | [61.3](/filings/0001699039-25-000084.md) | [59.7](/filings/0001628280-25-051148.md) | [69.2](/filings/0001699039-26-000001.md) | [95.8](/filings/0001699039-26-000001.md) |
| Total liabilities | $m | [90.8](/filings/0001699039-23-000099.md) | [113](/filings/0001699039-23-000128.md) | [106](/filings/0001699039-25-000015.md) | [93.8](/filings/0001699039-24-000067.md) | [99.1](/filings/0001699039-24-000095.md) | [106](/filings/0001699039-24-000121.md) | [108](/filings/0001628280-26-015248.md) | [104](/filings/0001699039-25-000050.md) | [105](/filings/0001699039-25-000084.md) | [103](/filings/0001628280-25-051148.md) | [119](/filings/0001699039-26-000001.md) | [159](/filings/0001699039-26-000001.md) |
| Long-term debt | $m | [0.0](/filings/0001699039-23-000099.md) | [0.0](/filings/0001699039-23-000128.md) | [0.0](/filings/0001699039-25-000015.md) | [0.0](/filings/0001699039-24-000067.md) | [0.0](/filings/0001699039-24-000095.md) | [0.0](/filings/0001699039-24-000121.md) | [0.0](/filings/0001699039-25-000015.md) | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.3](/filings/0001699039-23-000099.md) | [10.3](/filings/0001699039-23-000128.md) | [0.1](/filings/0001699039-25-000015.md) | [0.0](/filings/0001699039-24-000067.md) | [0.0](/filings/0001699039-24-000095.md) | [0.0](/filings/0001699039-24-000121.md) | [0.0](/filings/0001628280-26-015248.md) | [0.0](/filings/0001699039-25-000050.md) | not reported | not reported | [3.5](/filings/0001699039-26-000001.md) | [26.8](/filings/0001699039-26-000001.md) |
| Shareholders' equity | $m | [274](/filings/0001699039-23-000099.md) | [281](/filings/0001699039-23-000128.md) | [272](/filings/0001699039-25-000015.md) | [262](/filings/0001699039-24-000067.md) | [261](/filings/0001699039-24-000095.md) | [268](/filings/0001699039-24-000121.md) | [274](/filings/0001628280-26-015248.md) | [273](/filings/0001699039-25-000050.md) | [277](/filings/0001699039-25-000084.md) | [270](/filings/0001628280-25-051148.md) | [300](/filings/0001699039-26-000001.md) | [300](/filings/0001699039-26-000001.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [23.5 d](/filings/0001699039-24-000095.md) | [12.2 d](/filings/0001699039-24-000121.md) | [37.7 d](/filings/0001699039-25-000015.md) | [12.0](/filings/0001699039-25-000050.md) | [22.1 d](/filings/0001699039-25-000084.md) | [17.7 d](/filings/0001628280-25-051148.md) | [32.7 d](/filings/0001628280-26-015248.md) | [10.6](/filings/0001699039-26-000001.md) | [20.7 d](/filings/0001699039-25-000084.md) | [13.6 d](/filings/0001628280-25-051148.md) | [24.1 d](/filings/0001628280-26-015248.md) | [(3.4)](/filings/0001699039-26-000001.md) |
| Capital expenditure | $m | [7.5 d](/filings/0001699039-24-000095.md) | [15.0 d](/filings/0001699039-24-000121.md) | [8.6 d](/filings/0001699039-25-000015.md) | [6.5](/filings/0001699039-25-000050.md) | [15.3 d](/filings/0001699039-25-000084.md) | [6.9 d](/filings/0001628280-25-051148.md) | [5.4 d](/filings/0001628280-26-015248.md) | [7.2](/filings/0001699039-26-000001.md) | [6.3 d](/filings/0001699039-25-000084.md) | [5.6 d](/filings/0001628280-25-051148.md) | [7.0 d](/filings/0001628280-26-015248.md) | [18.3](/filings/0001699039-26-000001.md) |
| Dividends paid | $m | not reported | [1.2](/filings/0001699039-24-000121.md) | [1.2 d](/filings/0001699039-25-000015.md) | [0.0](/filings/0001699039-25-000050.md) | [2.3 d](/filings/0001699039-25-000084.md) | [1.1](/filings/0001699039-24-000121.md) | [1.1 d](/filings/0001628280-26-015248.md) | [1.3](/filings/0001699039-26-000001.md) | [1.5 d](/filings/0001699039-25-000084.md) | [1.3 d](/filings/0001628280-25-051148.md) | [1.4 d](/filings/0001628280-26-015248.md) | [0.0](/filings/0001699039-26-000001.md) |
| Share repurchases | $m | [5.5 d](/filings/0001699039-24-000095.md) | [2.7 d](/filings/0001699039-24-000121.md) | [10.7 d](/filings/0001699039-25-000015.md) | [8.5](/filings/0001699039-25-000050.md) | [5.3 d](/filings/0001699039-25-000084.md) | [1.7 d](/filings/0001628280-25-051148.md) | [0.0 d](/filings/0001628280-26-015248.md) | [0.0](/filings/0001699039-26-000001.md) | [3.3 d](/filings/0001699039-25-000084.md) | [8.2 d](/filings/0001628280-25-051148.md) | [0.7 d](/filings/0001628280-26-015248.md) | [0.5](/filings/0001699039-26-000001.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.6](/filings/0001699039-23-000099.md) | [25.2](/filings/0001699039-23-000128.md) | [25.2](/filings/0001699039-24-000067.md) | [25.2](/filings/0001699039-24-000095.md) | [24.9](/filings/0001699039-24-000121.md) | [22.9](/filings/0001699039-25-000050.md) | [22.5](/filings/0001699039-25-000084.md) | [22.5](/filings/0001628280-25-051148.md) | [23.1](/filings/0001699039-26-000001.md) | [22.7](/filings/0001699039-25-000084.md) | [22.1](/filings/0001628280-25-051148.md) | [24.0](/filings/0001699039-26-000001.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.